Media coverage
14
Media coverage
Title SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients Media name/outlet Morningstar.com Country/Territory United States Date 12/03/24 URL https://www.morningstar.com/news/globe-newswire/9062039/seastar-medical-provides-updates-on-enrollment-of-adult-pivotal-clinical-study-and-commercial-launch-of-quelimmune-fda-approved-in-pediatric-patients Persons Kevin Chung Title SeaStar Medical Provides Updates On Enrollment Of Adult Pivotal Clinical Study And Commercial Launch Of Quelimmune, FDA-Approved In Pediatric Patients Media name/outlet BENZINGA Newswire Country/Territory United States Date 12/03/24 Persons Kevin Chung Title SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients Media name/outlet Street Insider Country/Territory United States Date 12/03/24 URL https://www.streetinsider.com/Press+Releases/SeaStar+Medical+Provides+Updates+on+Enrollment+of+Adult+Pivotal+Clinical+Study+and+Commercial+Launch+of+Quelimmune%2C+FDA-Approved+in+Pediatric+Patients/22917262.html Persons Kevin Chung Title SeaStar Medical (ICU) Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune Media name/outlet Street Insider Country/Territory United States Date 12/03/24 URL https://www.streetinsider.com/Corporate+News/SeaStar+Medical+%28ICU%29+Provides+Updates+on+Enrollment+of+Adult+Pivotal+Clinical+Study+and+Commercial+Launch+of+Quelimmune/22917318.html Persons Kevin Chung Title SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients Media name/outlet BioSpace Country/Territory United States Date 12/03/24 URL https://www.biospace.com/article/releases/seastar-medical-provides-updates-on-enrollment-of-adult-pivotal-clinical-study-and-commercial-launch-of-quelimmune-fda-approved-in-pediatric-patients/ Persons Kevin Chung Title SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients Media name/outlet ADVFN UK Country/Territory United Kingdom Date 12/03/24 URL https://uk.advfn.com/stock-market/NASDAQ/ICU/share-news/SeaStar-Medical-Provides-Updates-on-Enrollment-of/93472326 Persons Kevin Chung Title SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients Media name/outlet Yahoo! Finance Country/Territory United States Date 12/03/24 URL https://finance.yahoo.com/news/seastar-medical-provides-updates-enrollment-123000972.html Persons Kevin Chung Title SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients Media name/outlet MarketScreener.com Country/Territory United States Date 12/03/24 URL https://www.marketscreener.com/quote/stock/SEASTAR-MEDICAL-HOLDING-C-146043601/news/SeaStar-Medical-Provides-Updates-on-Enrollment-of-Adult-Pivotal-Clinical-Study-and-Commercial-Launch-46150431/ Persons Kevin Chung Title SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients Media name/outlet Stockwatch Country/Territory Canada Date 12/03/24 URL www.stockwatch.com/News/Item/U-z9062039-U!ICU-20240312/U/ICU Persons Kevin Chung Title SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients Media name/outlet ADVFN US Country/Territory United States Date 12/03/24 URL https://www.advfn.com/stock-market/NASDAQ/ICU/stock-news/93472326/seastar-medical-provides-updates-on-enrollment-of-adult-pivotal-clinical-study-a Persons Kevin Chung Title SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients Media name/outlet Crwe World Country/Territory United States Date 12/03/24 URL crweworld.com/article/news-provided-by-globenewswire/3332130/seastar-medical-provides-updates-on-enrollment-of-adult-pivotal-clinical-study-and-commercial-launch-of-quelimmune-fda-approved-in-pediatric-patients Persons Kevin Chung Title SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients Media name/outlet Wallstreet Online Country/Territory Germany Date 12/03/24 URL https://www.wallstreet-online.de/nachricht/17880690-seastar-medical-provides-updates-on-enrollment-of-adult-pivotal-clinical-study-and-commercial-launch-of-quelimmune-fda-approved-pediatric-patients Persons Kevin Chung Title Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA Approved in Pediatric Patients Media name/outlet Market News Publishing Country/Territory United States Date 12/03/24 Persons Kevin Chung Title SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients Media name/outlet GlobeNewswire Country/Territory United States Date 12/03/24 URL https://www.globenewswire.com/news-release/2024/03/12/2844531/0/en/SeaStar-Medical-Provides-Updates-on-Enrollment-of-Adult-Pivotal-Clinical-Study-and-Commercial-Launch-of-Quelimmune-FDA-Approved-in-Pediatric-Patients.html Persons Kevin Chung